Patapsco Bancorp Inc (PATD) 4.8000 $PATD Howard Bancorp,

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Patapsco Bancorp Inc (PATD) 4.8000 $PATD

Howard Bancorp, Inc. Announces Results for the First Quarter of 2016
BusinessWire - Fri Apr 22, 8:28AM CDT
Howard Bancorp, Inc. (Nasdaq: HBMD) (the "Company", the parent company of Howard Bank (the "Bank", today reported its financial results for the quarter ended March 31, 2016 with the following highlights:
HBMD: 13.00 (-0.02)

Howard Bancorp, Inc. Announces Third Quarter 2015 Results with Asset Growth of 61% and Revenue Growth of 57%
BusinessWire - Fri Oct 30, 10:40AM CDT
Howard Bancorp, Inc. (NASDAQ: HBMD), the parent company of Howard Bank, today announced its operating results through September 30, 2015 with the following highlights:
HBMD: 13.00 (-0.02)

Howard Bancorp and Patapsco Bancorp Merger Receive all Necessary Stockholder Approvals
BusinessWire - Thu Jul 23, 3:59PM CDT
Howard Bancorp, Inc. ("Howard" (Nasdaq: HBMD), announced that on July 22, 2015, its stockholders approved the issuance by Howard of its shares of common stock to the stockholders of Patapsco Bancorp, Inc. ("Patapsco" in connection with the merger of Patapsco into Howard, with Howard as the surviving entity, pursuant to that Agreement and Plan of Merger by and between Howard and Patapsco dated as of March 2, 2015 ("the merger". Howard's stockholders showed overwhelming support for the merger-related share issuance with over 99% of the votes cast voting in favor of the proposal.
HBMD: 13.00 (-0.02)

Howard Bancorp Receives Regulatory Approval for the Acquisition of Patapsco Bancorp, Inc.
BusinessWire - Tue Jun 09, 3:15PM CDT
Howard Bancorp, Inc. (NASDAQ: HBMD) announced today that it, along with its banking subsidiary, Howard Bank, have received all required regulatory approvals necessary to proceed with the acquisition of Patapsco Bancorp, Inc., and its banking subsidiary, The Patapsco Bank. The transaction will be voted upon by stockholders of both Howard Bancorp and Patapsco Bancorp at meetings scheduled for July 22, 2015. The deal is anticipated to close on or about August 28, 2015, pending stockholder approval.
HBMD: 13.00 (-0.02)

Howard Bancorp, Inc. Completes $25 Million Common Stock Offering
BusinessWire - Tue Jun 02, 1:46PM CDT
Howard Bancorp, Inc. (NASDAQ: HBMD, "Howard", the parent company of Howard Bank, announced today that it has closed on its previously-announced private placement following receipt of stockholder approval. Howard issued an aggregate of 2,173,913 shares of its common stock at a price of $11.50 per share for approximately $25 million in gross proceeds to a limited number of well-regarded previously disclosed institutional bank investors. Howard solicited these capital commitments over a 30-day period beginning in early February and executed agreements with each investor on March 2, 2015. The purchase price represents the closing price of Howard's common stock on the day the offering was commenced and less than a 10% discount to the rolling 20-day average on the date of announcement of the private placement. Howard intends to use the proceeds of the private placement in part to support its acquisition of Patapsco Bancorp, Inc. ("Patapsco" as well as to support continued organic and acquired growth for the combined institution. Howard has no present intent to use the proceeds of the private placement to redeem its preferred stock issued to the U.S. Department of the Treasury under its Small Business Lending Fund (SBLF) program. The Patapsco transaction is subject to various stockholder and regulatory approvals and is expected to close in the third quarter of 2015.
HBMD: 13.00 (-0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading